Osler, Hoskin & Harcourt LLP advised Inversago Pharma on the matter. On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised BoostSecurity on the financing. On November 16, 2022, BoostSecurity announced it had secured $12 million in seed funding led by...
You must be a Standard 1 Year member to access this content.
Fasken supported NuChem Sciences Inc. on the acquisition of IniXium Inc., assisted by Osler, Hoskin & Harcourt LLP. Blakes represented the Fonds de solidarité FTQ. NuChem...
You must be a Standard 1 Year member to access this content.
White & Case and Osler, Hoskin & Harcourt LLP advised Inversago Pharma Inc. on the deal, while Wilson Sonsini advised NEA. Inversago Pharma Inc., a clinical-stage...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Milestone Pharmaceuticals Inc., while McCarthy Tétrault advised Jefferies Finance. Milestone Pharmaceuticals Inc. completed its $45 million public offering. The offering...
You must be a Standard 1 Year member to access this content.
